IPSEY:OTCMKTS
Ipsen ADR Rep 1/4 Ord Shs
$40.65
0.00%
(0.00) 1D
Okt 9, 3:39:16 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa IPSEY...
Mkt. cap
12.15B
Avg. na dami
1.40K
Dami
220.00
Mataas nang 52-wk
$51.10
Mababa nang 52-wk
$32.68
Beta
0.41
Mga natitirang share
335.26M
Bilang ng mga empleyado
6K
Mkt. cap
12.15B
Avg. na dami
1.40K
Dami
220.00
Mataas nang 52-wk
$51.10
Mababa nang 52-wk
$32.68
Beta
0.41
Mga natitirang share
335.26M
Bilang ng mga empleyado
6K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
CNBC
·
9 oras ang nakalipas
Jim Cramer says the bull market's remarkable 4-year run offers a crucial lesson for investors
The Guardian
·
6 araw ang nakalipas
S&P 500 and Nasdaq surge to record highs after AI chipmaker rally
Bloomberg.com
·
1 linggo ang nakalipas
S&P 500 Closes In on Record High as Tech Rallies: Markets Wrap
Investor's Business Daily
·
19 oras ang nakalipas
Tech Futures Fall, Oil Rises Amid Trump Comments
Profile
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia
Tungkol sa Ipsen ADR Rep 1/4 Ord Shs